Dana Horakova

Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic, Czech Republic

Poster(s):

• (B-106) Adherence to risk minimization measures for alemtuzumab use in Multiple Sclerosis: a drug utilisation study in four European countries
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-208) Leveraging multiple-country data sources for a comparative drug safety study: complexities and rewards in pharmacoepidemiology
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-327) The risk of mortality in patients with Multiple Sclerosis treated with alemtuzumab compared to other disease modifying therapies: A cohort study with data from five countries
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET